Newer pathophysiologic concepts about Asthma developed during the last decade, of being a chronic and an inflammatory disease, lead to changes in the way to focus the therapy of the asthma patients. Medicaments that were once considered as of first choice are now our third and/or fourth choice, but drugs that were used on the latter stages of the disease, we recommend lo be used early. These new changes in the treatment of asthma, together with the will to educate not only the asthmatic patient but his or her family as well, the adequate use of the inhalers with chambers, and the ~t uses of the Peak Flow are likely to decrease morbidity and morta1ity of the disease in the future.